- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06352905
Acute Effects of Whole Body Vibration for Individuals With Parkinson Disease
Impact of Whole Body Vibration on Backward Walking in Individuals With Parkinson's Disease: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will provide valuable information towards the relationship between backward walking using the 3-minute backward walk test and whole body vibration (WBV). The 3MBWT has shown to have diagnostic accuracy for fall prediction in older adults. The 3MBWT has been found to be feasible within the acute stroke population. In a study, the 3MBWT revealed that in the geriatric population a score of more than 4.5 seconds were likely to report a fall history. Gait parameters including a decrease in gait velocity (p<0.01) have been found to worsen while performing dual tasks (serial-7 subtraction) in individuals with PD. Research has shown when compared to other cognitive tests, the "serial sevens" tests increased the time required to perform the Timed Up and Go in individuals with PD.
This study will use a control group performing mid-squats on level ground and an intervention group performing mid-squats on a WBV machine. Each group will perform 5 sets of mid-squats for 60 seconds with a 60 second rest period between each set. Pre and post testing will involve three trials of the 3MBWT.
The purpose of this study is to determine the immediate impact of WBV on backward walking velocity in individuals diagnosed with PD.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Assistant Vice Provost for Research
- Phone Number: 254-710-3708
- Email: IRB@baylor.edu
Study Contact Backup
- Name: Anne Boddy
- Phone Number: 904-806-3126
- Email: anne_boddy@baylor.edu
Study Locations
-
-
Texas
-
Waco, Texas, United States, 76798
- Recruiting
- Baylor University
-
Contact:
- Anne Boddy
- Phone Number: 904-806-2126
- Email: anne_boddy@baylor.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosed with Parkinson disease (PD)
- classified Hoehn and Yahr stages I - IV
- ability to walk independently for at least 5 minutes
- alert and oriented to person, place and time
- Age between 40-85 years old
Exclusion Criteria:
- Deep-Brain Stimulation surgery less than 24 months prior to the start of the study
- physician changes in Deep-Brain Stimulation parameters during the study
- acute orthopedic injury or surgery that could impact gait
- a neurological condition other than PD
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: WBV Intervention
Participants will complete testing on the 3 meter backward test (3MBWT) for 3 trials (pretest).
Participants will perform mid-squats on a whole body vibration (WBV) platform.
The participant will complete the WBV with the platform next to a wall so they can use the wall for balance if needed.
Additionally, supervision or hand held assist will be provided if needed for balance by a licensed physical therapist.
After the completion of the WBV session, the participant will complete testing 3MBWT for 3 trials (posttest).
All participants will have a gait belt donned the entire time and be closely guarded during every test by a licensed physical therapist.
At any point the participant appears unsafe to continue, the protocol will stop immediately.
Participants will be given the option to stop and rest when needed.
|
WBV is a platform that vibrates while a person stands or sits and performs exercises.
The WBV session will consist of 5 sets of 60 seconds set at 6 Hertz (frequency), 3 mm (amplitude) while performing mid-squats.
There will be a 1 minute rest in between each set.
These parameters were chosen as commonly used parameters in previous studies of WBV in people with PD.
|
Active Comparator: Control group
Participants will complete testing on the 3 meter backward test (3MBWT) for 3 trials (pretest).
Participants will perform 5 sets of 60 seconds of mid-squats on level ground.
There will be a 1 minute rest in between each set.
The participant will complete the mid-squats next to a wall so they can use the wall for balance if needed.
Additionally, supervision or hand held assist will be provided if needed for balance by a licensed physical therapist.
After the completion of the the mid-squats, the participant will complete testing 3MBWT for 3 trials (posttest).
All participants will have a gait belt donned the entire time and be closely guarded during every test by a licensed physical therapist.
At any point the participant appears unsafe to continue, the protocol will stop immediately.
Participants will be given the option to stop and rest when needed.
|
Mid-squats performed on level ground 5 repetitions of 60 seconds with 1 minute rest in between each set.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3-meter backward walk test (3MBWT)
Time Frame: 5 minutes
|
The 3MBWT has excellent intrarater reliability as a backward walking velocity assessment.
This standardized measure demonstrates diagnostic accuracy for predicting falls within a year in healthy older adults and people with Parkinson disease.
Participants stand with their heel touching a line of tape on the floor and are instructed to initiate backward walking at the verbal cue "start" and to continue until instructed to stop (3 meters) by the tester guarding.
The average of 3 trials is the score.
|
5 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Dincher A, Schwarz M, Wydra G. Analysis of the Effects of Whole-Body Vibration in Parkinson Disease - Systematic Review and Meta-Analysis. PM R. 2019 Jun;11(6):640-653. doi: 10.1002/pmrj.12094. Epub 2019 May 6.
- Tarakad A, Jankovic J. Diagnosis and Management of Parkinson's Disease. Semin Neurol. 2017 Apr;37(2):118-126. doi: 10.1055/s-0037-1601888. Epub 2017 May 16.
- Hackney ME, Earhart GM. Backward walking in Parkinson's disease. Mov Disord. 2009 Jan 30;24(2):218-23. doi: 10.1002/mds.22330.
- Kwon KY, Park S, Lee HM, Park YM, Kim J, Kim J, Koh SB. Backward Gait is Associated with Motor Symptoms and Fear of Falling in Patients with De Novo Parkinson's Disease. J Clin Neurol. 2019 Oct;15(4):473-479. doi: 10.3988/jcn.2019.15.4.473.
- Fritz NE, Worstell AM, Kloos AD, Siles AB, White SE, Kegelmeyer DA. Backward walking measures are sensitive to age-related changes in mobility and balance. Gait Posture. 2013 Apr;37(4):593-7. doi: 10.1016/j.gaitpost.2012.09.022. Epub 2012 Nov 2.
- Rogan S, Taeymans J, Radlinger L, Naepflin S, Ruppen S, Bruelhart Y, Hilfiker R. Effects of whole-body vibration on postural control in elderly: An update of a systematic review and meta-analysis. Arch Gerontol Geriatr. 2017 Nov;73:95-112. doi: 10.1016/j.archger.2017.07.022. Epub 2017 Aug 3.
- Arenales Arauz YL, Ahuja G, Kamsma YPT, Kortholt A, van der Zee EA, van Heuvelen MJG. Potential of Whole-Body Vibration in Parkinson's Disease: A Systematic Review and Meta-Analysis of Human and Animal Studies. Biology (Basel). 2022 Aug 19;11(8):1238. doi: 10.3390/biology11081238.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2157711
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Whole body vibration (WBV)
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States
-
Universidad Rey Juan CarlosCompleted
-
University of HailNot yet recruiting
-
University Hospital Inselspital, BerneBern University of Applied SciencesTerminated
-
Shepherd Center, Atlanta GAEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedSpinal Cord Injuries | Foot Drop | Spastic GaitUnited States
-
Riphah International UniversityCompleted
-
Children's Hospital of Eastern OntarioUniversity of Ottawa; Canadian Arthritis NetworkWithdrawnJuvenile Idiopathic ArthritisCanada
-
University of StrathclydeQueen Elizabeth National Spinal Injuries Unit, GlasgowUnknownOsteoporosis | Spinal Cord InjuryUnited Kingdom
-
Bagcilar Training and Research HospitalCompletedEffects of Vibration | Bone MassTurkey
-
Bagcilar Training and Research HospitalCompleted